Wed, Sep 17, 2014, 5:01 AM EDT - U.S. Markets open in 4 hrs 29 mins

Recent

% | $
Quotes you view appear here for quick access.

IntelliCell BioSciences, Inc. Message Board

  • btimnextmicrosoft btimnextmicrosoft Jun 14, 2013 12:50 PM Flag

    MORE FDA NEWS

    NEW YORK, June 14, 2013 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTC Pink: SVFC) announced today that on May 14, 2013 through June 2, 2013, its cellular laboratory facility underwent a thorough inspection by the FDA. The observations from the FDA inspection were provided to the company in the Form 483. The Company will respond to those observations in a timely manner. IntelliCell will take the necessary actions to address the relevant FDA observations.
    IntelliCell's Chairman and CEO, Dr. Steven Victor, stated, "Our Company is very pleased that the FDA has inspected our new flagship cellular laboratory. While there are many companies and physicians' practices in the cellular/regenerative medicine space that may attempt to avoid contact with the FDA, IntelliCell has adopted a more transparent approach. We will continue to work hard with the FDA to meet all cGTP requirements for the manufacturing of Human Cells, Tissues, and Cellular and Tissue-Base Products

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SVFC
0.00130.0000(0.00%)Sep 16 3:57 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.